CLB attends Biomanufacturing Strategy Meeting Europe 2022

October 11, 2022, Zurich – As a proud co-sponsor of the Biomanufacturing Strategy Meeting Europe 2022 organized by Proventa, Dr. Tim Calvert, VP of International Markets, Cheerland Biotechnology (CLB), met with executives from major biopharma companies including Novartis, Bayer, Biogen, among other European and US companies. Dr. Calvert introduced to meeting attendees CLB’s current offerings in biologics CDMO services, ranging from large scale commercial CMO to clinical stage PD and CMC.

Dr. Tim Calvert (left) at the Biomanufacturing Strategy Meeting Europe 2022

Cheerland Biotechnology, the World’s Local CDMO, strives to supply safe, effective, and affordable therapeutics to China and the rest of the world.

Dr. Tim Calvert is based in Scotland, UK and can be reached at:timcalvert@cheerlandgroup.com; Tel: +44-7519348104